| Description | Sonepcizumab (LT 1009) is a fully humanized monoclonal antibody against S1P. Sonepcizumab has anti-cancer activity and can be used to study metastatic renal cell carcinoma (mRCC) to prevent eye scarring after glaucoma filtration surgery. |
| Synonyms | LT 1009 |
| molecular weight | N/A |
| CAS | 1031360-18-5 |
| Storage | store at low temperature | store at -80°C | Shipping with blue ice. |
| References | 1. Pal SK, et al. A phase 2 study of the sphingosine-1-phosphate antibody sonepcizumab in patients with metastatic renal cell carcinoma. Cancer. 2017 Feb 15;123(4):576-582. |